Navigation Links
Tiens Biotech Group (USA) Reports Fourth Quarter and Twelve-Month Results
Date:3/28/2008

OTHER COMPREHENSIVE

INCOME

Foreign

currency

translation

adjustment 3,334,871 1,083,976 8,265,358 3,480,775

COMPREHENSIVE

INCOME $ 7,214,298 $ 6,986,603 $ 26,858,999 $ 29,772,852

EARNINGS PER SHARE,

BASIC AND

DILUTED $ 0.05 $ 0.08 $ 0.26 $ 0.37

WEIGHTED AVERAGE

NUMBER OF

SHARES 71,333,586 71,333,586 71,333,586 71,333,586

TIENS BIOTECH GROUP (USA), INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

AS OF DECEMBER 31, 2007 AND DECEMBER 31, 2006

A S S E T S

December 31, December 31,

2007 2006

CURRENT ASSETS:

Cash $ 48,678,945 $ 54,270,065

Accounts receivable, trade - related

parties, net of allowance for

doubtful accounts of $71,700 and

$86,776 as of December 31, 2007 and

December 31, 2006, respectively 14,268,229 12,926,670

Accounts receivable, trade - third

parties 104,398 18,135

Inventories 5,949,963 6,845,108

Other receivables 892,489 349,905

Other receivables - related parties 13,070,907 8,397,227

Employee advances 64,336 111,121

Prepaid expense 623,638 2,135,917

Total current assets 83,652,905 85,054,148

Property, plant and equipment, net 18,322,619 30,511,319

OTHER ASSETS:

Intangible assets
'/>"/>

SOURCE Tiens Biotech Group (USA), Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. deCODE genetics to Webcast Presentation at 15th Annual Future Leaders in the Biotech Industry Conference
2. EntreMed to Present at BioCentury Future Leaders in the Biotech Industry Conference
3. Epeius Biotechnologies Awarded U.S. Patent for Targeted Injectable Gene Delivery In Vivo
4. Millennium Biotechnologies, Inc. Signs Marketing and Distribution Agreement with Ferring Pharmaceuticals
5. Accurate Identification of Tumor Origin Using MicroRNAs is Published by Rosetta Genomics Scientists and Collaborators in Nature Biotechnology
6. ITSSD: Russia Can Secure Greatest Biotech Market Advances Following US, Not EU Innovation Model
7. Pharmacopeia to Present at the 15TH Annual Future Leaders in the Biotech Industry Conference
8. SGX Pharmaceuticals to Present at the BioCentury Future Leaders in the Biotech Industry Conference
9. Genetic Engineering & Biotechnology News reports on clinical trials in developing countries
10. Oncolytics Biotech Inc. Announces Issuance of 26th U.S. Patent
11. ProMetic and Sartorius Stedim Biotech collaborate on technology transfer deals in Asia
Post Your Comments:
*Name:
*Comment:
*Email: